天津武清龙济做包皮手术吗武清龙济医院男科有微信端吗,龙济男科电话查询,天津市龙济医院泌尿外科口碑如何,男科天津市龙济医院,天津武清龙济医院男科高端诊疗,武清龙济医院具体怎么走,验精子龙济

LOS ANGELES, April 11 (Xinhua) -- Drinking 100-percent fruit juice may offer disease-fighting benefits, a new study suggests.Fruit juice is linked with reduced risk of cancer, improved markers of heart health and cognitive decline, and increased antioxidant activity, according to the study published on Monday by the American Association for the Advancement of Science (AAAS).These protective health benefits are similar to those of whole fruits, said the study, conducted by researchers at the University of California, Davis.The researchers came to the conclusion after summarizing recent research data on the potential benefits of fruit juice. The review included a range of study types, from in vitro to clinical trials (60 papers total), all published in 2005 or later.Among the fruit juices included in the review, consumption of apple, citrus, cranberry, grape, and pomegranate juices all showed beneficial effects. Markers of improved health ranged from reductions in urinary tract infections (cranberry) to improvements in age-related cognitive decline (grape and apple) to reduced risk of prostate (pomegranate) and respiratory and digestive (orange, grapefruit) cancers. Additionally, intake of all juices was linked to heightened antioxidant activity."While it is universally accepted that fruit and vegetable intake is protective, there is not a clear consensus about the benefits of consuming the juices that are extracted from them," said study lead author Dianne Hyson, PhD. "An analysis of the scientific evidence suggests that 100 percent fruit juices retain important bioactive components that may promote good health and aid in disease prevention."

BEIJING, March 11 (Xinhuanet) --Women who have a cup or more of coffee everyday may reduce their risk of stroke by as much as 25 percent, according to a new study in the Journal Stroke Thursday. This study, led by Swedish researcher Susanna Larsson of the Karolinska Institute in Stockholm, followed more than 34,000 Swedish women aged 49 to 83 who were free of heart disease. After 10-year of follow-up, there were 1,680 strokes, and the study found that those who drank at least one cup of coffee each day had a 22 to 25 percent lowered risk of stroke, compared with women who drank less.The study further suggested coffee can help prevent cognitive decline and can boost vision and heart health. It is also related to a reduced risk of liver cancer."We used to worry that (coffee) raises blood pressure and causes increased heart rate, but it appears to be less risky than we thought," said physician Claudette Brooks, spokesperson for the American Stroke Association. Now, exactly what it is about coffee that may lower stroke risk is unknown. But the researchers speculated that coffee might reduce inflammation, lower oxidative stress and help make the body more responsive to insulin.However, some experts kept skeptical about the real impact coffee would have on reducing the incidence of stroke."The problem with this type of study is that there are too many factors unaccounted for and association does not prove causality," Dr Larry B. Goldstein, director of the Duke Stroke Center at Duke University Medical Center said."Subjects were asked about their past coffee consumption in a questionnaire and then followed over time. There is no way to know if they changed their behavior," Goldstein added.In any case, the good news for coffee junkies is that at least drinking coffee don't increase women's risk of stroke.

LOS ANGELES, May 23 (Xinhua) -- NASA's Gravity Recovery And Interior Laboratory spacecraft (Grail) will begin final preparations for a launch on a Moon mission in late summer, the Jet Propulsion Laboratory (JPL) said on Monday.The dynamic duo will orbit the moon to determine the structure of the lunar interior from crust to core and to advance understanding of the thermal evolution of the moon, according to JPL in Pasadena, Los Angeles.After arriving at the Astrotech payload processing facility in Titusville, Florida last week, the Grail twins, known as Grail-A and Grail-B, were removed from their shipping containers Monday. Later this week, they will begin functional testing to verify their state of health, said JPL.The twins were shipped from Lockheed Martin Space Systems, Denver.Over the next four months at the Astrotech facility, the spacecraft will undergo final testing, fueling and packaging in the shroud that will protect them as the Delta II launch vehicle lifts them into space. The spacecraft will then be transported to the Cape Canaveral Air Force Station for installation atop the rocket that will carry them toward the moon, JPL said."We're only a few full moons away from a mission that will reveal clues not only into the history of the moon and Earth, but will provide important data for future lunar exploration," said Maria Zuber, Grail's principal investigator, based at the Massachusetts Institute of Technology.Grail will be carried into space aboard a United Launch Alliance Delta II Heavy rocket lifting off from Launch Complex-19 at the Cape Canaveral Air Force Station in Florida. The launch period opens Sept. 8, 2011, and extends through Oct. 19. For a Sept. 8 liftoff, the launch window opens at 5:37 a.m. PDT (8:37 a.m. EDT) and remains open through 6:16 a.m. PDT (9:16 a.m. EDT).Grail-A and Grail-B will fly in tandem orbits around the moon for several months to measure its gravity field in unprecedented detail.The mission will also answer longstanding questions about Earth' s moon, and provide scientists a better understanding of how Earth and other rocky planets in the solar system formed, according to JPL, which manages the Grail mission.

LOS ANGELES, April 7 (Xinhua) -- Using NASA's Galaxy Evolution Explorer (GEE) satellite, U.S. astronomers are hunting for nearby, hard-to-see stars which could very well be home to the easiest-to-see alien planets, it was announced on Thursday.U.S. astronomers are ferreting out the new targets after the glare of bright, shining stars has frustrated most efforts at visualizing distant worlds, NASA's Jet Propulsion Laboratory (JPL) said.So far, only a handful of distant planets, or exoplanets, have been directly imaged. Small, newborn stars are less blinding, making the planets easier to see, but the fact that these stars are dim means they are hard to find in the first place."Fortunately, the young stars emit more ultraviolet light than their older counterparts, which makes them conspicuous to the ultraviolet-detecting GEE," JPL said in a press release."We've discovered a new technique of using ultraviolet light to search for young, low-mass stars near the Earth," said David Rodriguez, a graduate student of astronomy at University of Californian, Los Angeles. "These young stars make excellent targets for future direct imaging of exoplanets."Young stars, like human children, tend to be a bit unruly -- they spout a greater proportion of energetic X-rays and ultraviolet light than more mature stars. In some cases, X-ray surveys can pick out these youngsters due to the "racket" they cause. However, many smaller, less "noisy" baby stars perfect for exoplanet imaging studies have gone undetected except in the most detailed X-ray surveys. To date, such surveys have covered only a small percentage of the sky, according to JPL in Pasadena, Los Angeles.Rodriguez and his team figured that the GEE, which has scanned about three-quarters of the sky in ultraviolet light, could fill this gap.Astronomers compared readings from the telescope with optical and infrared data to look for the telltale signature of rambunctious junior stars. Follow-up observations of 24 candidates identified in this manner determined that 17 of the stars showed clear signs of youth, validating the team's approach, JPL said."The Galaxy Evolution Explorer can readily select young, low- mass stars that are too faint to turn up in all-sky X-ray surveys, which makes the telescope an incredibly useful tool," Rodriguez said in the release.

WASHINGTON, May 11 (Xinhua) -- Researchers at Brigham and Women 's Hospital (BWH), a teaching affiliate of Harvard Medical School, have identified a human lung stem cell that is self-renewing and capable of forming and integrating multiple biological structures of the lung. This research will be published Thursday in the New England Journal of Medicine."This research describes, for the first time, a true human lung stem cell. The discovery of this stem cell has the potential to offer those who suffer from chronic lung diseases a totally novel treatment option by regenerating or repairing damaged areas of the lung," said the study's corresponding author Piero Anversa, who is also director of the Center for Regenerative Medicine at the hospital.Using lung tissue from surgical samples, researchers identified and isolated the human lung stem cell and tested the functionality of the stem cell both in vitro and in vivo. Once the stem cell was isolated, researchers demonstrated in vitro that the cell was capable of dividing both into new stem cells and also into cells that would grow into various types of lung tissue. Next, researchers injected the stem cell into mice with damaged lungs. The injected stem cells differentiated into new bronchioles, alveoli and pulmonary vessel cells which not only formed new lung tissue, but also integrated structurally to the existing lung tissue in the mice.The researchers define this cell as truly "stem" because it fulfills the three categories necessary to fall under stem cell categorization: first, the cell renews itself; second, it forms into many different types of lung cells; and third, it is transmissible, meaning that after a mouse was injected with the stem cells and responded by generating new tissue, researchers were then able to isolate the stem cell in the treated mouse, and use that cell in a new mouse with the same results."These are the critical first steps in developing clinical treatments for those with lung disease for which no therapies exist. Further research is needed, but we are excited about the impact this discovery could have on our ability to regenerate or recreate new lung tissues to replace damaged areas of the lungs," said Joseph Loscalzo, chair of the Department of Medicine at BWH and co-author.